March 17, 2020
Life value
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
On 17 March 2020, Stellapharm J.V. Co., Ltd. (the “Stella” or “Company”) and Joint Operation Contractors of Bach Khoa Group & Takenaka organized groundbreaking ceremony for its Hormone – Steroid – Ointment Factory complying with EU-GMP and PIC/S in Vietnam – Singapore Industrial Park, Thuan An City, Binh Duong Province.
This future factory, along with other key projects simultaneously implemented, aims at upgrading Stella to a higher position in ASEAN and Asian pharmaceutical industry.
Total investment is budgeted to be 350 billion VND with the timeline for operation by Q2/2021.
The factory is projected to be modern facilities, utilities… with sophisticated high containment production equipment for hormone and steroid products. Its products will include various pharmaceutical forms (tablet, film-coated tablets, capsules, ointment, suppository…).
The whole system is designed to comply with EU-GMP requirements for products containing hazardous active ingredient with the capacity of :
Upon completion, this will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.
The factory, once operational, will help Stella expand its market share of hormone and steroids drugs, provide doctors as well as patients in Vietnam more access to pharmaceutical specialties with international standards at affordable prices.
It will also help Stella to expand further its global export portfolio and turnover to achieve its internationalization objective.
By implementing this project, Stellapharm J.V. Co., Ltd. wants to reassert its pioneer role in Vietnam pharmaceutical industry.
Stellapharm J.V. Co., Ltd. is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com
Due to our strategic development of the Company, we are pleased to announce the change of Company Name: STADA – VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019.
Address, Tax code, Telephone/Fax Number remains unchanged.
On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1